A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Settings

Clinical trial NCT07200128 · COMPLETED

Trial details

NCT number: NCT07200128
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Severe Alopecia Areata

Start date: 2025-02-03
Primary completion: 2025-05-30
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.